SCTB41 Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1/2: 1Phase 2/3: 1

Top Sponsors

Sinocelltech Ltd.2

Indications

Cancer2
Double Blind1
Advanced Malignant Solid Tumours1
Lung Cancer1

Other2 trials

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.

Phase 1/2

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.